- Filed
- Jul 15, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Jul 15, 2024 | 8.06M sh |
| Cash And Equivalents | Q2 2024 · May 31, 2024 | $469.2K |
| Cash And Equivalents | Q2 2024 · Nov 30, 2023 | $406.07K |
| Current Liabilities | Q2 2024 · May 31, 2024 | $19.45M |
| Current Liabilities | Q2 2024 · Nov 30, 2023 | $20.86M |
| Total Liabilities | Q2 2024 · May 31, 2024 | $73.31M |
| Total Liabilities | Q2 2024 · Nov 30, 2023 | $72.25M |
| Current Assets | Q2 2024 · May 31, 2024 | $10.16M |
| Current Assets | Q2 2024 · Nov 30, 2023 | $9.45M |
| Total Assets | Q2 2024 · May 31, 2024 | $62.57M |
| Total Assets | Q2 2024 · Nov 30, 2023 | $61.22M |
| Shares Diluted | Q2 2024 · May 31, 2023 | 8.33M sh |
| Shares Diluted | Q2 2024 · May 31, 2023 | 8.4M sh |
| Stock Repurchased | Q2 2024 · May 31, 2023 | $791.45K |
| Capex | Q2 2024 · May 31, 2023 | $1.83M |
| Operating Cash Flow | Q2 2024 · May 31, 2023 | $3.63M |
| Stockholders Equity | Q2 2024 · May 31, 2023 | −$858.38K |
| Stockholders Equity | Q2 2024 · Feb 28, 2023 | −$687.52K |
| Stockholders Equity | Q2 2024 · Nov 30, 2022 | −$1.52M |
| Eps Diluted | Q2 2024 · May 31, 2023 | $0.03 |
| Eps Diluted | Q2 2024 · May 31, 2023 | $0.12 |
| Eps Basic | Q2 2024 · May 31, 2023 | $0.03 |
| Eps Basic | Q2 2024 · May 31, 2023 | $0.12 |
| Sga Expense | Q2 2024 · May 31, 2023 | $4.04M |
| Sga Expense | Q2 2024 · May 31, 2023 | $7.92M |
| Rd Expense | Q2 2024 · May 31, 2023 | $304.68K |
| Rd Expense | Q2 2024 · May 31, 2023 | $383.52K |
| Net Income | Q2 2024 · May 31, 2023 | $220.98K |
| Net Income | Q2 2024 · May 31, 2023 | $987.79K |
| Operating Income | Q2 2024 · May 31, 2023 | $1.03M |
| Operating Income | Q2 2024 · May 31, 2023 | $2.71M |
| Cost Of Revenue | Q2 2024 · May 31, 2023 | $2.14M |
| Cost Of Revenue | Q2 2024 · May 31, 2023 | $4.21M |